All In MedTech

Device Trial Radar · NCT05650359

Study of the Use of Orthopulse Photobiomodulation

A Randomized and Controlled Study of the Use of Orthopulse Photobiomodulation for Acceleration of Orthodontic Tooth Movement With Fixed Appliances

Last checked: Nov 20, 2026Latest source record: Aug 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Oct 13, 2022

Primary completion

May 15, 2028

Study completion May 15, 2028

Sponsor

Lead sponsor
Biolux Technology GmbHNot on our public-company list
Sponsor type
Industry
Collaborators
medXteam GmbH
First posted
Dec 14, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.

Conditions

  • Orthodontics

Interventions

  • OrthoPulseDevice

    The OrthoPulse device is intended to accelerate orthodontic movement of teeth and reduce the overall treatment time for the patient. The device is intended to be used in conjunction with traditional orthodontic treatment with brackets and wires or aligners. OrthoPulse is an intra-oral (iO), Light Emitting Diode (LED) based, phototherapy device for the stimulation of metabolic activity of the alveolar bone, and the acceleration of orthodontic tooth movement during orthodontic treatment. The device uses safe, high-power LED arrays to produce photons at therapeutic wavelengths in the near infrared (nIR) portion of the light spectrum. OrthoPulse is an established device that uses low levels of light energy to stimulate the bone surrounding the roots of teeth and facilitate tooth movement which may reduce treatment time for braces or clear aligners.

  • No interventionOther

    No intervention

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary endpoint of this PMCF study is the rate of tooth alignment.Time frame: 42 days after start of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Private Practice

    Chandler, Arizona · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.